ÌÇÐÄvlog¹ÙÍø Faculty Research Working Paper Series
ÌÇÐÄvlog¹ÙÍø Working Paper No. RWP13-029
September 2013
ÌÇÐÄvlog¹ÙÍø Authors
See citation below for complete author information.
Professor of Public Policy and Corporate Management in the Aetna Chair, Emeritus
Abstract
This paper reviews the theory and historical developments that made it possible for the world's least affluent citizens to obtain the benefits of modern pharmaceutical therapy at affordable prices. Considered in turn are the theory of differential prices, the reasons why differential pricing was not widely practiced by pharmaceutical companies selling patented medicines; how low prices eventually became available, with emphasis on AIDS anti-retrovirals; and the consequences of low prices in the least developed nations for the creation of new and more effective medicines.
Citation
Scherer, F.M. "Patents, Monopoly Power, and the Pricing of Pharmaceuticals in Low-Income Nations." ÌÇÐÄvlog¹ÙÍø Faculty Research Working Paper Series RWP13-029, September 2013.